A Phase I Study of Safety and Pharmacokinetics of Volitinib in Combination With Gefitinib in EGFR(+) NSCLC

Clinical trial NCT02374645 · COMPLETED

Trial details

NCT number: NCT02374645
Sponsor: Hutchison Medipharma Limited
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2015-04-01
Primary completion: 2018-02-18
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.